Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Integra LifeSciences Holdings Corporation IART
$49.03
-$0.56 (-1.15%)
На 18:00, 12 мая 2023
+44.81%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
4048534492.00000000
-
week52high
62.99
-
week52low
40.67
-
Revenue
1557666000
-
P/E TTM
24
-
Beta
1.15363300
-
EPS
1.90000000
-
Last Dividend
0.00000000
-
Next Earnings Date
25 июл 2023 г. в 12:30
Описание компании
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 25 авг 2022 г. |
| Morgan Stanley | Equal-Weight | 25 июл 2022 г. | |
| Truist Securities | Hold | Hold | 20 июл 2022 г. |
| Citigroup | Neutral | Neutral | 17 мая 2022 г. |
| B of A Securities | Underperform | Underperform | 18 янв 2022 г. |
| Truist Securities | Hold | Hold | 17 окт 2022 г. |
| Jefferies | Hold | 12 окт 2022 г. | |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 27 окт 2022 г. |
| JMP Securities | Market Outperform | Market Outperform | 27 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
| Truist Securities | Hold | Hold | 20 дек 2022 г. |
| Citigroup | Neutral | Neutral | 12 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| De Witte Jan | D | 74025 | 431 | 18 янв 2023 г. |
| De Witte Jan | D | 0 | 431 | 18 янв 2023 г. |
| De Witte Jan | A | 431 | 431 | 18 янв 2023 г. |
| Mosebrook Jeffrey | D | 8552 | 279 | 08 дек 2022 г. |
| De Witte Jan | A | 74456 | 29441 | 01 ноя 2022 г. |
| ESSIG STUART | D | 0 | 159012 | 31 окт 2022 г. |
| Singh Harvinder | A | 11965 | 11965 | 12 окт 2022 г. |
| Evoli Lisa | D | 17997 | 1165 | 10 авг 2022 г. |
| Murphy Raymond G. | D | 40825 | 8000 | 05 авг 2022 г. |
| Evoli Lisa | D | 19162 | 293 | 03 авг 2022 г. |
Новостная лента
Integra's (IART) Q1 Earnings Match Estimates, Margins Contract
Zacks Investment Research
27 апр 2023 г. в 12:10
In CSS, Integra (IART) witnesses a good start to the year with double-digit growth in the CUSA product line and programmable valves as well as strong performance in instrument sales.
Integra LifeSciences (IART) Q1 Earnings Meet Estimates
Zacks Investment Research
26 апр 2023 г. в 08:24
Integra LifeSciences (IART) came out with quarterly earnings of $0.74 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.74 per share a year ago.
Integra LifeSciences to Host First Quarter 2023 Financial Results Conference Call on April 26, 2023
GlobeNewsWire
03 апр 2023 г. в 08:00
PRINCETON, N.J., April 03, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2023 financial results on Wednesday, April 26, 2023, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET.
Integra Lifesciences (IART) Q4 Earnings Top, Revenues Drop Y/Y
Zacks Investment Research
23 февр 2023 г. в 09:47
Integra LifeSciences (IART) delivers strong earnings growth in the fourth quarter amid challenging macro environment issues.
Integra LifeSciences Holdings Corporation (IART) Q4 2022 Earnings Call Transcript
Seeking Alpha
22 февр 2023 г. в 14:56
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q4 2022 Earnings Conference Call February 22, 2023 8:30 AM ET Company Participants Chris Ward - Senior Director, Investor Relations Jan De Witte - President & Chief Executive Officer Jeffrey Mosebrook - SVP, Chief Accounting Officer Mathieu Aussermeier - VP, Corporate FP&A, Investor Relations & Treasurer Conference Call Participants Vik Chopra - Wells Fargo Steve Lichtman - Oppenheimer & Co. Matthew Taylor - Jefferies Ryan Zimmerman - BTIG Richard Newitter - Truist Securities Jayson Bedford - Raymond James David Turkaly - JMP Securities Matthew O'Brien - Piper Sandler Operator Thank you for standing by and welcome to Integra LifeSciences Fourth Quarter and Full Year 2022 Financial Results Call. At this time, all participants are in a listen-only mode.